These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36911517)

  • 21. Valproic Acid Modifies Synaptic Structure and Accelerates Neurite Outgrowth Via the Glycogen Synthase Kinase-3β Signaling Pathway in an Alzheimer's Disease Model.
    Long ZM; Zhao L; Jiang R; Wang KJ; Luo SF; Zheng M; Li XF; He GQ
    CNS Neurosci Ther; 2015 Nov; 21(11):887-97. PubMed ID: 26385876
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tolfenamic acid inhibits GSK-3β and PP2A mediated tau hyperphosphorylation in Alzheimer's disease models.
    Zhang H; Wang X; Xu P; Ji X; Chi T; Liu P; Zou L
    J Physiol Sci; 2020 Jun; 70(1):29. PubMed ID: 32517647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MiR-539-5p Decreases amyloid β-protein production, hyperphosphorylation of Tau and Memory Impairment by Regulating PI3K/Akt/GSK-3β Pathways in APP/PS1 Double Transgenic Mice.
    Jiang Y; Zhang Y; Su L
    Neurotox Res; 2020 Aug; 38(2):524-535. PubMed ID: 32415525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apolipoprotein E and beta-amyloid (1-42) regulation of glycogen synthase kinase-3beta.
    Cedazo-Mínguez A; Popescu BO; Blanco-Millán JM; Akterin S; Pei JJ; Winblad B; Cowburn RF
    J Neurochem; 2003 Dec; 87(5):1152-64. PubMed ID: 14622095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulatory GSK-3β: Blood-Based Biomarker and Therapeutic Target for Alzheimer's Disease.
    Kumari S; Singh A; Singh AK; Yadav Y; Bajpai S; Kumar P; Upadhyay AD; Shekhar S; Dwivedi S; Dey AB; Dey S
    J Alzheimers Dis; 2022; 85(1):249-260. PubMed ID: 34776454
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Silencing [Formula: see text] Rescues Tau Pathologies and Memory Deficits through Rescuing PP2A and Inhibiting GSK-3β Signaling in Human Tau Transgenic Mice.
    Zhang Y; Ma RH; Li XC; Zhang JY; Shi HR; Wei W; Luo DJ; Wang Q; Wang JZ; Liu GP
    Front Aging Neurosci; 2014; 6():123. PubMed ID: 24987368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spatial learning deficit in transgenic mice that conditionally over-express GSK-3beta in the brain but do not form tau filaments.
    Hernández F; Borrell J; Guaza C; Avila J; Lucas JJ
    J Neurochem; 2002 Dec; 83(6):1529-33. PubMed ID: 12472906
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selectively silencing GSK-3 isoforms reduces plaques and tangles in mouse models of Alzheimer's disease.
    Hurtado DE; Molina-Porcel L; Carroll JC; Macdonald C; Aboagye AK; Trojanowski JQ; Lee VM
    J Neurosci; 2012 May; 32(21):7392-402. PubMed ID: 22623685
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, synthesis and biological evaluation of harmine derivatives as potent GSK-3β/DYRK1A dual inhibitors for the treatment of Alzheimer's disease.
    Liu W; Liu X; Tian L; Gao Y; Liu W; Chen H; Jiang X; Xu Z; Ding H; Zhao Q
    Eur J Med Chem; 2021 Oct; 222():113554. PubMed ID: 34098466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Naringin Protects against Tau Hyperphosphorylation in A
    Qiu Q; Lei X; Wang Y; Xiong H; Xu Y; Sun H; Xu H; Zhang N
    Behav Neurol; 2023; 2023():1857330. PubMed ID: 36844418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human tau accumulation promotes glycogen synthase kinase-3β acetylation and thus upregulates the kinase: A vicious cycle in Alzheimer neurodegeneration.
    Zhou Q; Li S; Li M; Ke D; Wang Q; Yang Y; Liu GP; Wang XC; Liu E; Wang JZ
    EBioMedicine; 2022 Apr; 78():103970. PubMed ID: 35339896
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Curcumin mediates presenilin-1 activity to reduce β-amyloid production in a model of Alzheimer's Disease.
    Xiong Z; Hongmei Z; Lu S; Yu L
    Pharmacol Rep; 2011; 63(5):1101-8. PubMed ID: 22180352
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of GSK-3beta activation and alpha7 nAChRs in Abeta(1-42)-induced tau phosphorylation in PC12 cells.
    Hu M; Waring JF; Gopalakrishnan M; Li J
    J Neurochem; 2008 Aug; 106(3):1371-7. PubMed ID: 18485099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of glycogen synthase kinase-3β by Angelica sinensis extract decreases β-amyloid-induced neurotoxicity and tau phosphorylation in cultured cortical neurons.
    Zhang Z; Zhao R; Qi J; Wen S; Tang Y; Wang D
    J Neurosci Res; 2011 Mar; 89(3):437-47. PubMed ID: 21259330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amyloid-beta-induced neurotoxicity is reduced by inhibition of glycogen synthase kinase-3.
    Koh SH; Noh MY; Kim SH
    Brain Res; 2008 Jan; 1188():254-62. PubMed ID: 18031715
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The active form of glycogen synthase kinase-3beta is associated with granulovacuolar degeneration in neurons in Alzheimer's disease.
    Leroy K; Boutajangout A; Authelet M; Woodgett JR; Anderton BH; Brion JP
    Acta Neuropathol; 2002 Feb; 103(2):91-9. PubMed ID: 11810173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effects of pre-moxibustion on expression of phosphorylated Tau protein and related protein kinases in hippocampal CA3 region of AD rats].
    Liu Q; Zhang Q; Li MX; Wang CY; Song ZS; Ding H; Shi KJ; Li Z; Tao SQ; Tang W
    Zhen Ci Yan Jiu; 2022 Jul; 47(7):573-9. PubMed ID: 35880272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of glycogen synthase kinase-3 beta mediates β-amyloid induced neuritic damage in Alzheimer's disease.
    DaRocha-Souto B; Coma M; Pérez-Nievas BG; Scotton TC; Siao M; Sánchez-Ferrer P; Hashimoto T; Fan Z; Hudry E; Barroeta I; Serenó L; Rodríguez M; Sánchez MB; Hyman BT; Gómez-Isla T
    Neurobiol Dis; 2012 Jan; 45(1):425-37. PubMed ID: 21945540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RNA Interference Silencing of Glycogen Synthase Kinase 3β Inhibites Tau Phosphorylation in Mice with Alzheimer Disease.
    Bian H; Bian W; Lin X; Ma Z; Chen W; Pu Y
    Neurochem Res; 2016 Sep; 41(9):2470-80. PubMed ID: 27255602
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isoform-selective decrease of glycogen synthase kinase-3-beta (GSK-3β) reduces synaptic tau phosphorylation, transcellular spreading, and aggregation.
    Amaral AC; Perez-Nievas BG; Siao Tick Chong M; Gonzalez-Martinez A; Argente-Escrig H; Rubio-Guerra S; Commins C; Muftu S; Eftekharzadeh B; Hudry E; Fan Z; Ramanan P; Takeda S; Frosch MP; Wegmann S; Gomez-Isla T
    iScience; 2021 Feb; 24(2):102058. PubMed ID: 33554064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.